References
- Gryglewski R J, Szczeklik A, Bieron K. Morphine antagonises prostaglandin El-mediated inhibition of human platelet aggregation. Nature 1975; 256: 56–57
- Ceriello A, Dello-Russo P, Niola O, Capezzuto C, Schimizzi S. Fibrinogen levels in opiate addicts. Thromb Haemost 1983; 50: 755
- Sharp B M, Keane W F, Suh H J, Gekker G, Tsukayama D, Peterson P K. Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages. Endocrinology 1985; 117: 793–795
- Falke N E, Fischer E G. Cell shape of polymorphonuclear leukocytes is influenced by opioids. Immunobiology 1985; 169: 532–539
- Lucchesi B R, Mullane K M. Leukocytes and ischemia-induced myocardial injury. Annu Rev Pharmacol Toxicol 1986; 26: 201–204
- Tippins J R, Antoniw J W, Alison M R, Garvey B, Maseri A. WEB 2086 inhibits neutrophil dependent increases in coronary resistance in blood perfused rabbit heart. Cardiovasc Res 1992; 26: 162–169
- Berliner S, Fishelson Z, Bruhis S, Kaufman H, Pinhas J, Aronson M. The phenomenon of leukergy: induction and detection of leukocyte aggregation in whole human blood. J Lab Clin Med 1987; 109: 575–582
- Galante A, Carta S, Domenici B, Pietroiusti A. Proposal of a new method to avoid misinterpretations in the evaluation of the leukergy test. Scand J Clin Lab Invest 1992; 52: 431–433
- Berliner S, Fuchs J, Seligsohn U, et al. Possible role of fibrinogen in the aggregation of white blood cells. Thromb Haemost 1987; 58: 749–752
- Worthen G S. Lipid mediators, neutrophils and endothelial injury. Am Rev Respir Dis 1987; 136: 455–458
- Jensen R, Olsen T S, Winther B B. Severe non-occlusive ischemic stroke in young heroin addicts. Acta Neurol Scand 1990; 81: 354–357
- Baskin D S, Hosobuchi Y. Naloxone reversal of ischaemic neurological deficits in man. Lancet 1981; 2: 272–275
- Bousigue Y, Giraud L, Fournie D, Tremoulet M. Naloxone reversal of neurologic deficit. Lancet 1982; 2: 618–619
- Olinger C P, Adams H P, Jr, Brott T G, et al. High-dose intravenous naloxone for the treatment of acute ischemic stroke. Stroke 1990; 21: 721–725
- Stone M C, Thorp J M. Plasma fibrinogen—A major coronary risk factor. J R Coll Gen Pract 1985; 35: 565–569
- Silvestrini M, Pietroiusti A, De Matteis C, Galante A. Leukocyte aggregation in patients with chronic cerebrovascular disease. Acta Neurologica Scandinavica., In press